Iambic Therapeutics
PrivateLast Round
Early Stage
VC
Apr 8, 2026
Total Funding Raised
$303M
Momentum Score
50 /100
Company Overview
Iambic Therapeutics is a biotechnology company that develops a quantum molecular simulation engine powered by artificial intelligence to expedite the discovery of small-molecule therapeutics with enhanced accuracy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iambic Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Iambic Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Apr 8, 2026 | ||||
| Series C | Nov 10, 2025 | ||||
| Series B Extension | Jun 18, 2024 | ||||
| Series B | Oct 3, 2023 | ||||
| Series A | Jul 14, 2021 |
Key People
Founding team and executive leadership
Iambic Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series B |
| Regeneron Ventures | Series C |
| OrbiMed | Series B, Series A |
| Catalio Capital Management | Series B, Series C, Series A |
| Sequoia Capital | Series B, Series A, Series C |
| Abingworth | Series B Extension, Series C, Series B |
| Shanda Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
$28M raised in early stage VC funding.
- Apr 3, 2026
Drug candidates advanced into human clinical trials.
Iambic Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Iambic Therapeutics's valuation, stock price, and market status.
